NewGenIvf Group Limited

NIVF Healthcare Medical Care Facilities

NewGenIvf Group Limited’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 13.0% from fiscal 2024. Dividend growth for five consecutive years; insiders bought in the last twelve months.

0.28 0.03 +12.00%
Market cap
$2.3M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
−0.24
Beneish M
7.81
Dividend safety
n/a

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Older periods Dec '24 Jun '25 Sep '25 Dec '25
Net Income

+2 more quarters

— 0.00 0.00 —
Other line items

Show all line items

value withheld pending a data check
In millions of $ except per-share values · columns are period end dates · fundamentals updated 9 Oct 2026